Aemetis, Inc (NASDAQ:AMTX - Get Free Report) shares crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $2.09 and traded as low as $1.8110. Aemetis shares last traded at $1.82, with a volume of 474,057 shares traded.
Analysts Set New Price Targets
A number of brokerages have weighed in on AMTX. Ascendiant Capital Markets raised their price objective on Aemetis from $21.00 to $22.00 and gave the company a "buy" rating in a report on Friday, May 22nd. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Aemetis in a research note on Friday, July 17th. Finally, Wall Street Zen raised shares of Aemetis from a "sell" rating to a "hold" rating in a report on Saturday, August 22nd. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $11.88.
Check Out Our Latest Stock Report on Aemetis
Aemetis Price Performance
The company has a market capitalization of $131.35 million, a PE ratio of -2.00 and a beta of 1.48. The business's 50 day simple moving average is $1.70 and its 200 day simple moving average is $2.09.
Aemetis (NASDAQ:AMTX - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The specialty chemicals company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.16. The firm had revenue of $62.70 million during the quarter, compared to analysts' expectations of $67.69 million. As a group, analysts anticipate that Aemetis, Inc will post -0.89 EPS for the current year.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in AMTX. Royal Bank of Canada raised its position in Aemetis by 10,632.5% in the first quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company's stock valued at $28,000 after purchasing an additional 8,825 shares during the period. Creative Planning acquired a new position in shares of Aemetis in the 2nd quarter valued at $30,000. Virtu Financial LLC purchased a new position in shares of Aemetis during the 4th quarter worth $31,000. Sanctuary Advisors LLC purchased a new position in shares of Aemetis during the 1st quarter worth $33,000. Finally, HRT Financial LP acquired a new stake in shares of Aemetis during the 4th quarter worth about $36,000. 27.02% of the stock is currently owned by hedge funds and other institutional investors.
About Aemetis
(
Get Free Report)
Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.
Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Aemetis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aemetis wasn't on the list.
While Aemetis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
